Menu Search

India

NX 100 Index - NSELast 5 days
Last price22,919.90
S&P/CNX 500Last 5 days
Last price20,264.35
S&P CNX Nifty Index - NSELast 5 days
Last price22,470.50
S&P CNX Defty - NSELast 5 days
Last price8,937.76
CNX IT Index - NSELast 5 days
Last price36,310.65
CNX Nifty Junior Index - NSELast 5 days
Last price59,277.55

Loading...

INR overview

PairLatest rateToday's change1 year change
INRGBP0.0089
GBP		0.000002 / 0.02%--
INREUR0.0105
EUR		0.00003 / 0.26%--
INRUSD0.0115
USD		0.000002 / 0.02%--
INRJPY1.71
JPY		0.0124 / 0.73%--
INRAUD0.0182
AUD		0.00003 / 0.16%--
INRCAD0.0165
CAD		-0.00003 / -0.20%--
INRCNY0.083
CNY		0.0001 / 0.17%--
INRCHF0.0101
CHF		0.000003 / 0.03%--

Equity fund country flows

This chart shows the cumulative weekly equity in country flows into or out of India in USD. EPFR Global provides global coverage of foreign investor flows, tracking over 15,000 funds domiciled around the world.
As of May 19 2021.

Market movers

Constituents of the NX 100 Index - NSE with the highest percent gain over one day.
ListingLastChangeVolume
Indusind Bank LtdINDUSINDBK:NSI684.70
INR		+28.75
+4.38%		108.68m
Tata Motors LtdTATAMOTORS:NSI668.30
INR		+20.25
+3.12%		18.73m
Kotak Mahindra Bank LtdKOTAKBANK:NSI1,982.55
INR		+47.35
+2.45%		6.70m
Bharat Forge LtdBHARATFORG:NSI1,090.20
INR		+25.90
+2.43%		770.99k
Divi's Laboratories LtdDIVISLAB:NSI5,667.15
INR		+120.90
+2.18%		345.39k
United Breweries LtdUBL:NSI1,910.65
INR		+32.35
+1.72%		130.85k
Aurobindo Pharma LtdAUROPHARMA:NSI1,107.90
INR		+17.25
+1.58%		895.45k
Glenmark Pharmaceuticals LtdGLENMARK:NSI1,422.30
INR		+22.10
+1.58%		715.46k
Gail (India) LtdGAIL:NSI159.20
INR		+2.42
+1.54%		12.86m
ITC LtdITC:NSI412.40
INR		+6.20
+1.53%		13.84m
Data delayed at least 15 minutes, as of Mar 12 2025 10:29 BST.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.